{"resourceType":"Condition","id":"47010","meta":{"versionId":"2","lastUpdated":"2022-12-19T17:06:26.289+01:00","source":"#SjJkBt3KMEUsw4dR","profile":["http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Condition-primaryCancer-eu-pcsp"]},"language":"ES","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/condition-assertedDate","valueDateTime":"2014-05-15"},{"url":"http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-histology-morphology-behavior","valueCodeableConcept":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"9836/3","display":"Leucemia linfoblástica de células B precursoras  ( maligno )  "}]}}],"bodySite":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"C42.1"}]}],"subject":{"reference":"Patient/47009"},"stage":[{"summary":{"text":"Muy alto riesgo"}}],"evidence":[{"code":[{"coding":[{"system":"http://snomed.info/sct","code":"106221001","display":"Evidencia de Marcadores Genéticos"}],"text":"BCR/ABL, MLL, E1A2, TEL/AML1 negativos"}]}]}
